Investments in research and development for supplemental drug indications: implications for drug price negotiations

Vokinger, Kerstin N., Perényi, Gellért and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2023) Investments in research and development for supplemental drug indications: implications for drug price negotiations. JAMA Health Forum, 4 (9). E232798. ISSN 2689-0186

Text (Investments in Research and Development for Supplemental Drug Indications —Implications for Drug Price Negotiations) - Published Version Available under License Creative Commons Attribution. Download (332kB)

• Author
• Scopus publication

Item Type:	Article
Additional Information:	© 2023 The Author(s)
Divisions:	Health Policy
Subjects:	R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine R Medicine R Medicine > RM Therapeutics. Pharmacology
Date Deposited:	06 Jul 2023 13:09
Last Modified:	18 Nov 2024 23:30
URI:	http://eprints.lse.ac.uk/id/eprint/119649

Actions (login required)

View Item